Physician profile
Ronald H Fields
NPI 1083681548
$372,576.21
in general payments reported to CMS, 2019-2025
58 companies · $1,404 in 2025
The $1,404 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156K · 2020: $63K · 2021: $62K · 2022: $33K · 2023: $38K · 2024: $20K · 2025: $1,404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $28K · Consulting Fee: $25K · Food and Beverage: $6,265 · Travel and Lodging: $27.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $28,430.00 |
| Consulting Fee | $25,020.00 |
| Food and Beverage | $6,265.42 |
| Travel and Lodging | $27.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $328,370.24 | 2019-2024 | Xarelto |
| Amgen INC. | $21,318.59 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $12,236.31 | 2019-2025 | |
| Boston Scientific Corporation | $1,466.43 | 2019-2025 | Watchman Access System, Avvigo Guidance System, Watchman Flx |
| Abiomed | $1,012.11 | 2019-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $924.78 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $831.38 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $600.33 | 2019-2025 | Farxiga, Wainua, Fasenra |
| Philips North America LLC | $526.93 | 2021-2025 | Extended Holter |
| Impulse Dynamics (USA) INC. | $494.89 | 2019-2025 | Optimizer, Optimizer |
| Amarin Pharma, INC. | $452.98 | 2019-2022 | |
| Novo Nordisk INC | $381.87 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Regeneron Healthcare Solutions, INC. | $308.99 | 2019-2024 | Dupixent |
| Medtronic, INC. | $278.86 | 2021-2024 | Endurant Iis, Avalus, Symplicity G3 |
| Merck Sharp & Dohme LLC | $271.14 | 2021-2025 | Verquvo |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $252.29 | 2021-2025 | Nexletol |
| Medtronic Vascular, INC. | $243.17 | 2019-2020 | |
| Abbott Laboratories | $237.83 | 2023-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip, Esprit |
| Sanofi-Aventis U.S. LLC | $217.97 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $182.44 | 2019-2025 | Lifevest |
| Astellas Pharma US INC | $164.77 | 2019-2020 | |
| Cook Medical LLC | $155.91 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $134.96 | 2024-2025 | Onpattro, Amvuttra |
| United Therapeutics Corporation | $125.00 | 2021 | |
| Argon Medical Devices, INC. | $89.80 | 2021 | |
| Vital Connect, INC | $76.07 | 2023 | Vitalpatch Rtm |
| Bridgebio Pharma, INC. | $71.76 | 2025 | Attruby |
| Kestra Medical Technology Services, INC. | $70.69 | 2022-2024 | Assure Wcd |
| Kowa Pharmaceuticals America, INC. | $69.27 | 2019-2021 | |
| Electromed, INC. | $68.56 | 2022-2023 | Smartvest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.91 | 2022-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $67.35 | 2022-2025 | |
| Portola Pharmaceuticals, LLC | $61.89 | 2019-2020 | |
| Edwards Lifesciences Corporation | $57.19 | 2023-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Atricure, INC. | $56.57 | 2019-2021 | |
| Agepha Pharma Fz LLC | $53.83 | 2024-2025 | Lodoco |
| Lundbeck LLC | $51.69 | 2019-2020 | |
| Shockwave Medical, INC | $47.90 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biosense Webster, INC. | $41.57 | 2021 | |
| Cardinal Health 200 LLC | $41.49 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $37.31 | 2023 | Arcalyst |
| Teleflex LLC | $35.81 | 2020-2025 | Arrow |
| Exact Sciences Corporation | $30.69 | 2023-2024 | Cologuard Collection Kit |
| Bardy Diagnostics, INC. | $30.00 | 2020 | |
| Althera Pharmaceuticals LLC | $28.21 | 2021 | |
| Altathera Pharmaceuticals LLC | $28.18 | 2022-2023 | Sotalol Hydrochloride |
| Baxter Healthcare | $26.74 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Daiichi Sankyo INC. | $26.72 | 2024 | Injectafer |
| Lexicon Pharmaceuticals, INC. | $26.70 | 2024 | |
| Inari Medical, INC. | $26.34 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cardiovascular Systems INC. | $21.32 | 2023 | Diamondback Peripheral |
| Inspire Medical Systems, INC. | $17.00 | 2024 | Inspire |
| W. L. Gore & Associates, INC. | $14.50 | 2019 | |
| Chiesi USA, INC. | $12.18 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.94 | 2019 | |
| Terumo Medical Corporation | $10.92 | 2019 | |
| Janssen Biotech, INC. | $7.94 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Fields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.